Expert Recap

Early Breast Cancer: Endocrine Therapy

Source: Endocrine*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Early Breast Cancer: Endocrine Therapy

Faculty:
Harold J. Burstein, MD, PhD

CME CREDIT INFORMATION

Release Date: 02/27/08

Expiration Date: 02/26/09

Physicians: maximum of 0.75 AMA PRA Category 1 Credit(s)™

Registered Nurses: 0.7 Nursing CE credit

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Summarize the results of recent studies of adjuvant and neoadjuvant chemotherapy for the treatment of breast cancer
Discuss therapies designed to preserve the musculoskeletal health for women on hormonal therapy
Describe how CYP2D6 polymorphisms may affect the efficacy of tamoxifen in women with estrogen receptor–positive breast cancer

CCO Expert Recaps combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.